About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 160726, 10 pages
http://dx.doi.org/10.1155/2012/160726
Research Article

Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling

1Institute of Liver Diseases, ShuGuang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
3Shanghai Key Laboratory of Traditional Chinese Clinic Medicine, Shanghai 201203, China
4E-Institute of TCM Internal Medicine, Shanghai Municipal Education Commission, Shanghai 201203, China

Received 10 July 2012; Revised 30 September 2012; Accepted 10 October 2012

Academic Editor: Adair Roberto Soares Santos

Copyright © 2012 Shu Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Roskams, “Relationships among stellate cell activation, progenitor cells, and hepatic regeneration,” Clinics in Liver Disease, vol. 12, no. 4, pp. 853–860, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. K. Moreira, “Hepatic stellate cells and liver fibrosis,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 11, pp. 1728–1734, 2007. View at Scopus
  3. S. K. Das and D. M. Vasudevan, “Genesis of hepatic fibrosis and its biochemical markers,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 4, pp. 260–269, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Paizis, R. E. Gilbert, M. E. Cooper et al., “Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis,” Journal of Hepatology, vol. 35, no. 3, pp. 376–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Jonsson, A. D. Clouston, Y. Ando et al., “Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis,” Gastroenterology, vol. 121, no. 1, pp. 148–155, 2001. View at Scopus
  6. H. Yoshiji, S. Kuriyama, J. Yoshii et al., “Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats,” Hepatology, vol. 34, no. 4, pp. 745–750, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Bataller, P. Ginès, J. M. Nicolás et al., “Angiotensin II induces contraction and proliferation of human hepatic stellate cells,” Gastroenterology, vol. 118, no. 6, pp. 1149–1156, 2000. View at Scopus
  8. R. Bataller, P. Sancho-Bru, P. Ginès et al., “Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II,” Gastroenterology, vol. 125, no. 1, pp. 117–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Paizis, M. E. Cooper, J. M. Schembri, C. Tikellis, L. M. Burrell, and P. W. Angus, “Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver,” Gastroenterology, vol. 123, no. 5, pp. 1667–1676, 2002. View at Scopus
  10. R. Bataller, E. Gäbele, R. Schoonhoven et al., “Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 3, pp. G642–G651, 2003. View at Scopus
  11. E. E. Powell, C. J. Edwards-Smith, J. L. Hay et al., “Host genetic factors influence disease progression in chronic hepatitis C,” Hepatology, vol. 31, no. 4, pp. 828–833, 2000. View at Scopus
  12. X. Li, Y. Meng, P. Wu, Z. Zhang, and X. Yang, “Angiotensin II and Aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat,” Regulatory Peptides, vol. 138, no. 1, pp. 15–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Yang, R. Bataller, J. Dulyx et al., “Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice,” Journal of Hepatology, vol. 43, no. 2, pp. 317–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. X. N. Wang, Y. Y. Hu, C. H. Liu, P. Liu, and D. Y. Zhu, “Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis,” Zhong Xi Yi Jie He Xue Bao, vol. 3, no. 4, pp. 286–289, 2005. View at Scopus
  15. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. P. Marshall, R. J. McAnulty, and G. J. Laurent, “Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 1999–2004, 2000. View at Scopus
  17. A. Douillette, A. Bibeau-Poirier, S. P. Gravel et al., “The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IκB kinase complex,” Journal of Biological Chemistry, vol. 281, no. 19, pp. 13275–13284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ruiz-Ortega, O. Lorenzo, M. Rupérez, Y. Suzuki, and J. Egido, “Angiotensin II activates nuclear transcription factor-κB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice,” Nephrology Dialysis Transplantation, vol. 16, supplement 1, pp. 27–33, 2001. View at Scopus
  19. H. Jin, N. Yamamoto, K. Uchida, S. Terai, and I. Sakaida, “Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient l-amino acid-defined diet,” Biochemical and Biophysical Research Communications, vol. 364, no. 4, pp. 801–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. F. J. Yu, P. H. Dong, X. F. Fan, Z. Lin, Y. P. Chen, and J. Li, “Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cells,” International Journal of Molecular Medicine, vol. 25, no. 5, pp. 801–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Hirose, M. Ono, T. Saibara et al., “Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis,” Hepatology, vol. 45, no. 6, pp. 1375–1381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Nabeshima, S. Tazuma, K. Kanno et al., “Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4- induced liver fibrosis,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 658–664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Kanno, S. Tazuma, and K. Chayama, “AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4,” Biochemical and Biophysical Research Communications, vol. 308, no. 1, pp. 177–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. C. Rockey, “Current and future anti-fibrotic therapies for chronic liver disease,” Clinics in Liver Disease, vol. 12, no. 4, pp. 939–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Liu, Y. Y. Hu, C. Liu et al., “Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B,” World Journal of Gastroenterology, vol. 11, no. 19, pp. 2892–2899, 2005. View at Scopus
  26. C. Liu, C. M. Jiang, C. H. Liu, P. Liu, and Y. Y. Hu, “Effect for Fuzhenghuayu decoction on vascular endothelial growth factor secretion in hepatic stellate cells,” Hepatobiliary and Pancreatic Diseases International, vol. 1, no. 2, pp. 207–210, 2002. View at Scopus
  27. C. Liu, P. Liu, C. H. Liu, X. Q. Zhu, and G. Ji, “Effects of Fuzhenghuayu decoction on collagen synthesis of cultured hepatic stellate cells, hepatocytes and fibroblasts in rats,” World Journal of Gastroenterology, vol. 4, no. 6, pp. 548–549, 1998. View at Scopus
  28. C. Liu, C. Jiang, C. Liu, P. Liu, and Y. Hu, “Intervention of Fuzhenghuayu decoction on autocrine activation of hepatic stellate cells,” Zhonghua Gan Zang Bing Za Zhi, vol. 9, no. 5, pp. 282–284, 2001. View at Scopus
  29. P. Liu, Y. Y. Hu, C. Liu et al., “Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B,” World Journal of Gastroenterology, vol. 8, no. 4, pp. 679–685, 2002. View at Scopus
  30. L. Wang, Y. Tao, S. Li, G. Chen, and C. Liu, “Effects of salvianolic acid B on lipid peroxidation and metalloproteinase-2 activity in fibrotic liver in rat,” Zhongguo Zhongyao Zazhi, vol. 35, no. 1, pp. 71–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Friedman, D. C. Rockey, R. F. McGuire, J. J. Maher, J. K. Boyles, and G. Yamasaki, “Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture,” Hepatology, vol. 15, no. 2, pp. 234–243, 1992. View at Scopus
  32. M. A. Sohail, A. Z. Hashmi, W. Hakim et al., “Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition,” Hepatology, vol. 49, no. 1, pp. 185–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Moreno, L. N. Ramalho, P. Sancho-Bru et al., “Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 2, pp. G147–G156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Y. Kim, B. H. Cho, and U. H. Kim, “CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation,” Journal of Biological Chemistry, vol. 285, no. 1, pp. 576–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Wang, C. liu, Y. Chen, Y. Tao, T. Zhou, and G. A. Cheng, “Modified methed to create rat model of hepatic fibrosis with dimethylnitrosamine and its pathological characteristics,” Acta Laroratorium Animalis Scientia Sinca, vol. 17, no. 2, pp. 90–94, 2007.
  36. S. Vogel, R. Piantedosi, J. Frank et al., “An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro,” Journal of Lipid Research, vol. 41, no. 6, pp. 882–893, 2000. View at Scopus
  37. J. Liu, H. Gong, Z. T. Zhang, and Y. Wang, “Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells,” Chinese Medical Journal, vol. 121, no. 2, pp. 161–165, 2008. View at Scopus
  38. H. S. Wei, H. M. Lu, D. G. Li et al., “The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCL4,” World Journal of Gastroenterology, vol. 6, no. 6, pp. 824–828, 2000. View at Scopus
  39. P. Moreno-Alvarez, M. Sosa-Garrocho, M. A. Briones-Orta et al., “Angiotensin II increases mRNA levels of all TGF-β isoforms in quiescent and activated rat hepatic stellate cells,” Cell Biology International, vol. 34, no. 10, pp. 969–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Lv, Y. Song, D. Xue, W. Zhang, Y. Cheng, and L. Xu, “Effect of Salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells,” Journal of Ethnopharmacology, vol. 132, no. 2, pp. 384–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. H. J. Schaeffer and M. J. Weber, “Mitogen-activated protein kinases: specific messages from ubiquitous messengers,” Molecular and Cellular Biology, vol. 19, no. 4, pp. 2435–2444, 1999. View at Scopus
  42. G. L. Johnson and R. Lapadat, “Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases,” Science, vol. 298, no. 5600, pp. 1911–1912, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Wada and J. M. Penninger, “Mitogen-activated protein kinases in apoptosis regulation,” Oncogene, vol. 23, no. 16, pp. 2838–2849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Chang, L. S. Steelman, J. T. Lee et al., “Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention,” Leukemia, vol. 17, no. 7, pp. 1263–1293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. P. K. Vogt, “Jun, the oncoprotein,” Oncogene, vol. 20, no. 19, pp. 2365–2377, 2001. View at Publisher · View at Google Scholar · View at Scopus